Fanyan Meng

机构：Anshun University, First Affiliated Hospital of Liaoning Medical University, Nanjing Drum Tower Hospital, Jiangsu Cancer Hospital, First Hospital of China Medical University, Nanjing University, China Medical University · ORCID：0000-0003-1187-7644

发表论文 84 篇 · 总被引 3624 次 · h-index 25

代表论文

• Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy (2022 · Nature Communications · 被引 111)
• Neoantigen-targeted TCR-T cell therapy for solid tumors: How far from clinical application (2022 · Cancer Letters · 被引 43)
• Biomarkers for predicting tumor response to PD-1 inhibitors in patients with advanced pancreatic cancer (2023 · Human Vaccines & Immunotherapeutics · 被引 29)
• Coix seed oil alleviates synovial angiogenesis through suppressing HIF-1α/VEGF-A signaling pathways via SIRT1 in collagen-induced arthritis rats (2023 · Chinese Medicine · 被引 25)
• Nanomodified Switch Induced Precise and Moderate Activation of CAR‐T Cells for Solid Tumors (2023 · Advanced Science · 被引 19)
• DDR2 Coordinates EMT and Metabolic Reprogramming as a Shared Effector of FOXQ1 and SNAI1 (2022 · Cancer Research Communications · 被引 15)